Amy Sarjeant
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amy Sarjeant has a total of 230 co-authors. Here are the top co-authors by number of shared publications:
- Alicia Regueiro-Ren
Bristol-Myers Squibb, P.O. Box 4000, Princeton, New Jersey 08543, United States
4 shared publications Darpandeep Aulakh
Department of Materials Science and Engineering, Bristol-Myers Squibb, New Brunswick, New Jersey 08903, United States
3 shared publicationsHyunsoo Park
Bristol Myers Squibb Co, Drug Prod Dev, New Brunswick, NJ 08903 USA
3 shared publications- Louise Nicole Dawe
Wilfrid Laurier University
3 shared publications - Michael D. Mandler
Bristol-Myers Squibb (United States)
3 shared publications Sarah C. Traeger
Small Molecule Drug Discovery, Bristol Myers Squibb Research and Early Development, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
3 shared publications
Latest Publications
- 7 July 2026
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 26 (15) , 6035-6049
Reinvestigation of the Isonicotinamide-Fluorobenzoic Acid Cocrystal: New Insights from Novel Forms
The serendipitous formation of two new forms of isonicotinamide:4-fluorobenzoic acid cocrystal system is reported in this study. The structural landscape of this cocrystal system has been investigated using theoretical calculations and mechanical grinding. The landscape has been further studied using isonicotinamide:benzoic acid structures as probes. The acid···pyridine heterosynthon is the basis of the crystal packing in all the obtained cocrystals. Interestingly, the acid···amide heterosynthon is observed in disordered Form-II, which is a 2:1 cocrystal. Form-II also elicits the question of whether the crystallized form is a twinned triclinic or a disordered monoclinic system.
- 7 July 2026
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 26 (15) , 6035-6049
Reinvestigation of the Isonicotinamide-Fluorobenzoic Acid Cocrystal: New Insights from Novel Forms
The serendipitous formation of two new forms of isonicotinamide:4-fluorobenzoic acid cocrystal system is reported in this study. The structural landscape of this cocrystal system has been investigated using theoretical calculations and mechanical grinding. The landscape has been further studied using isonicotinamide:benzoic acid structures as probes. The acid···pyridine heterosynthon is the basis of the crystal packing in all the obtained cocrystals. Interestingly, the acid···amide heterosynthon is observed in disordered Form-II, which is a 2:1 cocrystal. Form-II also elicits the question of whether the crystallized form is a twinned triclinic or a disordered monoclinic system.
- 22 June 2026
- Published by American Chemical Society (ACS) in Organometallics
- Vol. 45 (16) , 1920-1927
Shelf-Stable Bis(perfluoroaryl)nickel(II) Complexes for Organometallic Synthesis and Catalysis
We describe two bis(perfluoroaryl)nickel(II) complexes, Ni(C6F5)2(NCPh)2 and [NBu4]2[{Ni(C6F5)2(μ–OH)2}2], as bench-stable, broadly soluble, and readily coordinating Ni(II) sources for applications in organometallic synthesis and catalysis. Their catalytic competence is demonstrated across representative transformations, including Suzuki–Miyaura coupling, Buchwald–Hartwig amination, Miyaura borylation, and recently developed alkene difunctionalization reactions, with performance comparable to or exceeding that of conventional Ni sources. The presumed activation pathway via reductive elimination of decafluorobiphenyl offers a benign route, minimizing off-cycle species formation.
- 22 June 2026
- Published by American Chemical Society (ACS) in Organometallics
- Vol. 45 (16) , 1920-1927
Shelf-Stable Bis(perfluoroaryl)nickel(II) Complexes for Organometallic Synthesis and Catalysis
We describe two bis(perfluoroaryl)nickel(II) complexes, Ni(C6F5)2(NCPh)2 and [NBu4]2[{Ni(C6F5)2(μ–OH)2}2], as bench-stable, broadly soluble, and readily coordinating Ni(II) sources for applications in organometallic synthesis and catalysis. Their catalytic competence is demonstrated across representative transformations, including Suzuki–Miyaura coupling, Buchwald–Hartwig amination, Miyaura borylation, and recently developed alkene difunctionalization reactions, with performance comparable to or exceeding that of conventional Ni sources. The presumed activation pathway via reductive elimination of decafluorobiphenyl offers a benign route, minimizing off-cycle species formation.
- 3 December 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 90 (49) , 17322-17331
Desymmetrization of meso -Anhydride Enabled Enantioselective Synthesis of (−)-7-(Bromomethylene)-3-amidobicyclo[2.2.1]heptane-2-carboxamide, a Scaffold for Divergent Drug Discovery Synthesis
An enantioselective synthesis (>99% ee) of (-)-(1R,2S,3R,4R,Z)-7-(bromomethylene)-N-(4-fluoro-3-(trifluoromethyl)phenyl)-3-(2,2,2-trifluoroacetamido)bicyclo[2.2.1]heptane-2-carboxamide ((-)-1), a scaffold for divergent drug discovery synthesis, has been developed. The synthesis employed dimethyl(phenyl)silyl moiety as a "masked" hydroxy group and started with an exclusively endo selective Diels-Alder reaction of readily available cyclopenta-2,4-dien-1-yldimethyl(phenyl)silane (8) with maleic anhydride (3) to afford the tricyclic anhydride 17. Desymmetrization of this meso-anhydride 17 was enabled by a high yielding quinidine-mediated opening with benzyl alcohol to generate the benzyl hemiester 4 with >93% ee which was upgraded to greater than 99% ee by chiral resolution with (1R,2R)-(-)-1,2-diaminocyclohexane 19. Other key features of this synthetic route involved a Curtius rearrangement for the formation Teoc-protected amino bicyclo[2.2.1]heptane intermediate 23, a Fleming-Tamao oxidation for the conversion of dimethyl(phenyl)silyl to the hydroxy group and a Swern oxidation of the alcohol 30 to the strained-ring ketone 31. Finally, the bromo olefin of (-)-1 was installed by a stereoselective Wittig reaction of 31 using (bromomethyl)triphenylphosphonium bromide.
- 3 December 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 90 (49) , 17322-17331
Desymmetrization of meso -Anhydride Enabled Enantioselective Synthesis of (−)-7-(Bromomethylene)-3-amidobicyclo[2.2.1]heptane-2-carboxamide, a Scaffold for Divergent Drug Discovery Synthesis
An enantioselective synthesis (>99% ee) of (-)-(1R,2S,3R,4R,Z)-7-(bromomethylene)-N-(4-fluoro-3-(trifluoromethyl)phenyl)-3-(2,2,2-trifluoroacetamido)bicyclo[2.2.1]heptane-2-carboxamide ((-)-1), a scaffold for divergent drug discovery synthesis, has been developed. The synthesis employed dimethyl(phenyl)silyl moiety as a "masked" hydroxy group and started with an exclusively endo selective Diels-Alder reaction of readily available cyclopenta-2,4-dien-1-yldimethyl(phenyl)silane (8) with maleic anhydride (3) to afford the tricyclic anhydride 17. Desymmetrization of this meso-anhydride 17 was enabled by a high yielding quinidine-mediated opening with benzyl alcohol to generate the benzyl hemiester 4 with >93% ee which was upgraded to greater than 99% ee by chiral resolution with (1R,2R)-(-)-1,2-diaminocyclohexane 19. Other key features of this synthetic route involved a Curtius rearrangement for the formation Teoc-protected amino bicyclo[2.2.1]heptane intermediate 23, a Fleming-Tamao oxidation for the conversion of dimethyl(phenyl)silyl to the hydroxy group and a Swern oxidation of the alcohol 30 to the strained-ring ketone 31. Finally, the bromo olefin of (-)-1 was installed by a stereoselective Wittig reaction of 31 using (bromomethyl)triphenylphosphonium bromide.
- 14 October 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (20) , 21840-21859
Design, Synthesis, and T Cell Checkpoint Combination Potential Of First-In-Class DGKα/ζ Inhibitor BMS-986408
DGKα and DGKζ are intracellular T cell checkpoints that negatively regulate T cell signaling, activation, and tumor immunity. Inhibition of DGKα/ζ is an attractive mechanism for next-generation immunotherapy, with the potential to broaden the response to existing cancer treatments, including anti-PD-1 and anti-CTLA-4. The lead molecule BMS-502 was optimized to the first-in-class dual DGKα/ζ inhibitor BMS-986408 (BMS-408), starting with the replacement of an aryl nitro group that posed a potential liability. Subsequent improvement in cellular potency, cross-species oral pharmacokinetic profile, and optimization of physicochemical properties led to the identification of the development candidate BMS-408. In preclinical studies, BMS-408 demonstrated dose-proportional pharmacokinetics and pharmacodynamics in mice, as well as robust efficacy in combination with either anti-PD-1 and/or anti-CTLA-4 in MC-38 and 1956 tumor models. Given the favorable in vitro and in vivo profiles, as well as in vivo pharmacology, BMS-408 was advanced to clinical development.
- 14 October 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (20) , 21840-21859
Design, Synthesis, and T Cell Checkpoint Combination Potential Of First-In-Class DGKα/ζ Inhibitor BMS-986408
DGKα and DGKζ are intracellular T cell checkpoints that negatively regulate T cell signaling, activation, and tumor immunity. Inhibition of DGKα/ζ is an attractive mechanism for next-generation immunotherapy, with the potential to broaden the response to existing cancer treatments, including anti-PD-1 and anti-CTLA-4. The lead molecule BMS-502 was optimized to the first-in-class dual DGKα/ζ inhibitor BMS-986408 (BMS-408), starting with the replacement of an aryl nitro group that posed a potential liability. Subsequent improvement in cellular potency, cross-species oral pharmacokinetic profile, and optimization of physicochemical properties led to the identification of the development candidate BMS-408. In preclinical studies, BMS-408 demonstrated dose-proportional pharmacokinetics and pharmacodynamics in mice, as well as robust efficacy in combination with either anti-PD-1 and/or anti-CTLA-4 in MC-38 and 1956 tumor models. Given the favorable in vitro and in vivo profiles, as well as in vivo pharmacology, BMS-408 was advanced to clinical development.
- 12 December 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (12) , 4513-4533
Development of an Inherently Safe and Scalable Nickel-Catalyzed Borylation Process of an Aryl Sulfamate
- 12 December 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (12) , 4513-4533
Development of an Inherently Safe and Scalable Nickel-Catalyzed Borylation Process of an Aryl Sulfamate
- Open Access
- 26 September 2024
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section C Structural Chemistry
- Vol. 80 (10) , 584
Introducing the Best practice in crystallography series
- 26 September 2024
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section C Structural Chemistry
- Vol. 80 (10) , 584
Open AccessIntroducing the Best practice in crystallography series
- Open Access
- 20 June 2024
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 24 (13) , 5486-5493
On the Road to Cocrystal Prediction: A Screening Study for the Validation of In Silico Methods
- 20 June 2024
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 24 (13) , 5486-5493
Open AccessOn the Road to Cocrystal Prediction: A Screening Study for the Validation of In Silico Methods
- 8 April 2024
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 26 (15) , 3103-3108
α-Alkylation and Asymmetric Transfer Hydrogenation of Tetralone via Hydrogen Borrowing and Dynamic Kinetic Resolution Strategy Using a Single Iridium(III) Complex
Here we present a novel strategy for the synthesis of enantiomerically enriched tetrahydronaphthalen-1-ols. The reaction proceeds via an alkylation (via hydrogen borrowing) and ammonium formate-mediated asymmetric transfer hydrogenation (via dynamic kinetic resolution), giving alkylated tetralols in high yields and good enantio- and diastereoselectivity across a diverse range of both alcohol and tetralone substrates. Additionally, these products were successfully derivatized to several complex molecules, demonstrating the utility of the tetrahydronaphthalen-1-ol.
- 8 April 2024
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 26 (15) , 3103-3108
α-Alkylation and Asymmetric Transfer Hydrogenation of Tetralone via Hydrogen Borrowing and Dynamic Kinetic Resolution Strategy Using a Single Iridium(III) Complex
Here we present a novel strategy for the synthesis of enantiomerically enriched tetrahydronaphthalen-1-ols. The reaction proceeds via an alkylation (via hydrogen borrowing) and ammonium formate-mediated asymmetric transfer hydrogenation (via dynamic kinetic resolution), giving alkylated tetralols in high yields and good enantio- and diastereoselectivity across a diverse range of both alcohol and tetralone substrates. Additionally, these products were successfully derivatized to several complex molecules, demonstrating the utility of the tetrahydronaphthalen-1-ol.
- 6 November 2023
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 52 (46) , 17249-17257
Controlled synthesis of polycarbonate diols and their polylactide block copolymers using amino-bis(phenolate) chromium hydroxide complexes
A chromium hydroxide diamino-bis(phenolate) complex copolymerizes cyclohexene oxide and CO2 to a polycarbonate diol, which acts as a macroinitiator for the polymerization of lactide to give a polycarbonate-block-polyester copolymer.
- 6 November 2023
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 52 (46) , 17249-17257
Controlled synthesis of polycarbonate diols and their polylactide block copolymers using amino-bis(phenolate) chromium hydroxide complexes
A chromium hydroxide diamino-bis(phenolate) complex copolymerizes cyclohexene oxide and CO2 to a polycarbonate diol, which acts as a macroinitiator for the polymerization of lactide to give a polycarbonate-block-polyester copolymer.
- Open Access
- 26 September 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Controlled Synthesis of Polycarbonate Diols and Their Polylactide Block Copolymers using Amino-bis(phenolate) Chromium Hydroxide Complexes
A diamine-bis(phenolate) chromium(III) complex, CrOH[L] ([L] = dimethylaminoethylamino-N,N-bis(2-methylene-4,6-tert-butylphenolate)), 2, in the presence of tetrabutylammonium hydroxide effectively copolymerizes CO2 and cyclohexene oxide (CHO) into polycarbonate diol. The resultant low molecular weight (6.3 kg mol–1) diol is used to initiate ring-opening polymerization of rac-lactide with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) giving ABA-type block copolymers with good molecular weight control through varying rac-LA-to-diol loading, and with narrow dispersities. As the degree of rac-LA incorporation increases, the glass transition temperatures (Tg) are found to decrease, whereas decomposition temperatures (Td) increase. Diphenylphosphonimido)triphenylphosphorane (Ph2P(O)NPPh3) was used as a neutral nucleophilic cocatalyst with 2, giving phosphorus-containing polycarbonates with Mn of 28.5 kg mol–1, dispersity of 1.13, Tg of 110 C and Td over 300 C. A related Cr(III) complex (4) having a methoxyethyl pendent group rather than a dimethylaminoethyl group was structurally characterized as a hydroxide-bridged dimer.
- 26 September 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessControlled Synthesis of Polycarbonate Diols and Their Polylactide Block Copolymers using Amino-bis(phenolate) Chromium Hydroxide Complexes
A diamine-bis(phenolate) chromium(III) complex, CrOH[L] ([L] = dimethylaminoethylamino-N,N-bis(2-methylene-4,6-tert-butylphenolate)), 2, in the presence of tetrabutylammonium hydroxide effectively copolymerizes CO2 and cyclohexene oxide (CHO) into polycarbonate diol. The resultant low molecular weight (6.3 kg mol–1) diol is used to initiate ring-opening polymerization of rac-lactide with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) giving ABA-type block copolymers with good molecular weight control through varying rac-LA-to-diol loading, and with narrow dispersities. As the degree of rac-LA incorporation increases, the glass transition temperatures (Tg) are found to decrease, whereas decomposition temperatures (Td) increase. Diphenylphosphonimido)triphenylphosphorane (Ph2P(O)NPPh3) was used as a neutral nucleophilic cocatalyst with 2, giving phosphorus-containing polycarbonates with Mn of 28.5 kg mol–1, dispersity of 1.13, Tg of 110 C and Td over 300 C. A related Cr(III) complex (4) having a methoxyethyl pendent group rather than a dimethylaminoethyl group was structurally characterized as a hydroxide-bridged dimer.